WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
WHO ’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countriesSince the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelinesTwelfth Roche medicine or test to be prequalified Basel, 11 February 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Actemra ®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification. Prequalification is a confi...
Source: Roche Investor Update - February 11, 2022 Category: Pharmaceuticals Source Type: news
In memoriam: Dr. Mark De Antonio, 67, psychiatrist who cared for vulnerable youth
Dr. Mark De Antonio, a clinical psychiatry professor at the Semel Institute for Neuroscience and Human Behavior at UCLA, died Dec. 31, after an extended illness. He was 67.De Antonio, who joined the faculty at UCLA in 1988, also served as director of inpatient child and adolescent psychiatric service at the Resnick Neuropsychiatric Hospital at UCLA. He was known for his passion to provide care for severely mentally ill and vulnerable youth, especially those with developmental disabilities. During his career, he received numerous accolades and awards for his teaching and clinical expertise.“De Antonio continued working up...
Source: UCLA Newsroom: Health Sciences - February 7, 2022 Category: Universities & Medical Training Source Type: news
Sweating the small stuff: Smartwatch developed at UCLA measures key stress hormone
The human body responds to stress, from the everyday to the extreme, by producing a hormone called cortisol.To date, it has been impractical to measure cortisol as a way to potentially identify conditions such as depression and post-traumatic stress, in which levels of the hormone are elevated. Cortisol levels traditionally have been evaluated through blood samples by professional labs, and while those measurements can be useful for diagnosing certain diseases, they fail to capture changes in cortisol levels over time.Now, a UCLA research team has developed a device that could be a major step forward: a smartwatch that ass...
Source: UCLA Newsroom: Health Sciences - February 7, 2022 Category: Universities & Medical Training Source Type: news
First patients of pioneering CAR T-cell therapy ‘cured of cancer’
Cancer-killing cells still present 10 years on, with results suggesting therapy is a cure for certain blood cancersTwo of the first human patients to be treated with a revolutionary therapy that engineers immune cells to target specific types of cancer still possess cancer-killing cells a decade later with no sign of their illness returning.The finding suggests CAR T-cell therapy constitutes a “cure” for certain blood cancers, although adapting it to treat solid tumours is proving more challenging.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 2, 2022 Category: Science Authors: Linda Geddes Science correspondent Tags: Cancer Medical research Society Science Health Immunology Biochemistry and molecular biology Source Type: news
Changes to the Roche Board of Directors and the Corporate Executive Committee
Basel, 1 February 2022Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that William Pao (1967), M.D., Ph.D., and Head of Roche Pharma Research and Early Development (pRED) since 2018, has decided to leave Roche for a new opportunity and return to the United States, effective 18 March 2022. Johannes (Hans) Clevers (1957), M.D., Ph.D., who joined the Board of Directors in 2019, will step down from this position and be appointed the new Head of Roche pRED effective 18 March 2022. Hans Clevers will become a member of the enlarged Corporate Executive Committee and will be based in Basel. A successor to Hans Clevers ’ board ...
Source: Roche Media News - February 1, 2022 Category: Pharmaceuticals Source Type: news
